Back to Top Skip to main content Skip to sub-navigation

AFMES missions continue through COVID-19

Two men sitting at a table going through sample bottles Navy Petty Officer 1st Class Edinmel Balterocruz (left) and Air Force Master Sgt. Jesson Pareja, both Armed Forces Medical Examiner System Forensic Toxicology laboratory technicians, accession samples for testing April 13, 2020. Balterocruz and Pareja and the Division of Forensic Toxicology continue to support national security and combatant commanders through timely and effective testing for the abuse of illicit drug threats. (U.S. Air Force photo by Tech. Sgt. Nicole Leidholm)

Recommended Content:

Armed Forces Medical Examiner System | Coronavirus

DOVER AIR FORCE BASE, Del. – The Armed Forces Medical Examiner System remains operational despite the COVID-19 pandemic.

“This has been a rapidly evolving situation in spite of the challenges we see with the stay-at-home order,” said U.S. Army Col. Louis Finelli, AFMES director. “The workload hasn’t changed, just the way we’re accomplishing the mission.”

AFMES is following guidance from the Centers for Disease Control and Prevention, State of Delaware and 436th Airlift Wing commander of social distancing and significantly reduced manning. The efforts are to minimize the spread of COVID-19 and to prioritize the health and safety of personnel.

“The organization conducted a critical mission analysis and determined the minimum number of employees required to accomplish the mission,” said Richard Gates, AFMES operations manager. “The footprint in the facility is at the absolute minimum and the majority of administrative work is covered by telework employees.”

Gates added, AFMES is a resilient organization that is committed to accomplishing the mission during the global pandemic.

In accordance with directives, AMFES began working in two-shifts to maintain operations, significantly reducing the number of employees in the facility to mission essential duties only.

“We have implemented a two-shift work environment that reduces the number of staff at work at any given time,” said U.S. Army Lt. Col. David Sartori, AFMES Forensic Toxicology director. “We have found that we are more efficient in completing our tasks and will explorer this work schedule as a potential long-term process.”

The DoD DNA Operations section has also adjusted to the guidance, working with only 12 percent of staff on each shift. Although work load has remained the same, sample processing and casework turn-around times have been severely impacted.

“We had to adopt to the reduced staffing levels needed to protect our people as well as maintain mission operations for the AFMES, [Defense POW/MIA Accounting Agency] and [military criminal investigative organizations] groups,” said Dr. Timothy McMahon, AFMES DoD DNA Operations director. “Due to DoD, State and Federal guidelines in regards to social distancing we are operating two 8-hour shifts and performing DNA testing for both the AFMES and the DPAA and assisting MCIO groups with priority criminal and missing persons casework and processing priority family reference samples to assist the DPAA with identifications.”

According to McMahon, the logistics of moving to a two-shift environment posed a challenge, with communication across the organization becoming paramount.

“I make sure that we are in constant contact with my employees so that they feel tied to the organization still and do not feel alone during this time,” said McMahon. “Communication has become key so that people understand what is going on and how we are protecting them while they are here at work.”

Even with the impacts of COVID-19, AFMES has persevered through the challenges in stride.

“It’s imperative that AFMES continues the mission during these trying times,” said Finelli. “I’m very proud of how AFMES has adjusted so quickly to our new routine.”

Disclaimer: Re-published content may be edited for length and clarity.  Read original post.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DoD Instruction 5154.30: Armed Forces Medical Examiner System AFMES Operations

Policy

This instruction establishes policy, assigns responsibilities, and provides direction for forensic medicine activities throughout DoD In accordance with the authority in DoD Directive (DoDD) 5124.02, and provides for the continued operation and governance of AFMES, a component of the Defense Health Agency (DHA) under DoDD 5136.13, in carrying out assigned functions, including those under Section 1471 of Title 10, United States Code (U.S.C.).

Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.